Improving stem cell mobilization strategies
EPO in combination with G-CSF improves mobilization effectiveness after chemotherapy with ifosfamide, epirubicin and etoposide and reduces costs during mobilization and transplantation of autologous hematopoietic progenitor cells
Outcome following unrelated cord blood transplant in 136 patients with malignant and non-malignant diseases
Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency
Contaminating tumour cells in autologous PBSC grafts do not influence survival or relapse following transplant for multiple myeloma or B-cell non-Hodgkin's lymphoma
Little impact of donor/recipient major mismatch for neutrophil-specific antigen NA2 on neutrophil recovery after allogeneic SCT
Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium
Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade)
Should busulfan-containing regimen be avoided for young female patients undergoing hematopoietic stem cell transplantation?
G-CSF-induced thrombocytopenia in a healthy donor